ABS-1230

ABS-1230 · Actio Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABS-1230, covering 2025-11-26 to 2025-11-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years [Phase 1]

See pricing